Sellas Life Sciences Group Inc (SLS) support and resistance · $1.62B cap
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
This page maps Sellas Life Sciences Group Inc (SLS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$9.6M. SLS currently screens at market cap $1.62B.
SLS currently screens at market cap $1.62B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SLS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SLS quote page for the session range and the stock page for the full model.
Not investment advice.